Literature DB >> 7521348

Effect of human galanin on growth hormone prolactin, and antidiuretic hormone secretion in normal men.

Y Murakami1, K Ohshima, T Mochizuki, N Yanaihara.   

Abstract

Galanin is a brain-gut peptide occurring widely in the central and peripheral nervous system. Effects of iv administration of synthetic human galanin on pituitary GH, PRL, and antidiuretic hormone secretion were studied. Intravenous infusion of the peptide resulted in a significant increase in plasma GH levels whereas PRL and antidiuretic hormone did not significantly change. These findings suggest that galanin might play a role in modulating GH secretion in humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7521348     DOI: 10.1210/jcem.77.5.7521348

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Galanin positively modulates prolactin secretion in normal women.

Authors:  S Grottoli; E Arvat; L Gianotti; J Ramunni; L Di Vito; B Maccagno; E Ciccarelli; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

Review 2.  Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.

Authors:  M P McDonald; J N Crawley
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

3.  Co-aggregation and secondary nucleation in the life cycle of human prolactin/galanin functional amyloids.

Authors:  Debdeep Chatterjee; Reeba S Jacob; Soumik Ray; Ambuja Navalkar; Namrata Singh; Shinjinee Sengupta; Laxmikant Gadhe; Pradeep Kadu; Debalina Datta; Ajoy Paul; Sakunthala Arunima; Surabhi Mehra; Chinmai Pindi; Santosh Kumar; Praful Singru; Sanjib Senapati; Samir K Maji
Journal:  Elife       Date:  2022-03-08       Impact factor: 8.713

4.  Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women.

Authors:  E Arvat; B Maccagno; J Ramunni; F Broglio; F Lanfranco; R Giordano; A Benso; R Deghenghi; E Ghigo
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.